MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/apt.15409

Медицинская библиотека · Alimentary pharmacology & therapeutics · 2019

Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival.

Matysiak-Budnik Tamara, Jamet Philippe, Ruskoné-Fourmestraux Agnès, de Mascarel Antoine, Velten Michel, Maynadié Marc, Woronoff Anne-Sophie, Trétarre Brigitte, Marrer Emilie, Delafosse Patricia, Ligier Karine, Lapôtre Ledoux Bénédicte, Daubisse Laetitia, Bouzid Laïla, Orazio Sébastien, Cowppli-Bony Anne, Monnereau Alain

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a rare disease, and most available data on gastric MALT lymphoma (GML) come from clinical studies of selected patients treated in centres of excellence.

AIMS: To analyse the clinical features, management and survival of GML patients in a population-based study in France

METHODS

All new cases of GML diagnosed between 2002 and 2010 in 11 French areas covered by cancer registries were included. Pathology reports were verified and, if necessary, reviewed by an expert pathologist. All clinical data were retrospectively collected from medical files and analysed using stata V. 14 software.

RESULTS

Four hundred and sixteen patients with confirmed GML (50% male, median age 67 years) were identified. Among them, 44 showed an early transformation into diffuse large B cell lymphoma and were considered to have had an initially missed high-grade lymphoma. At diagnosis, 76% of patients were at stage IE/II, and 24% at stage III/IV of the disease. Helicobacter pylori infection was found in 57% of the patients. Eradication treatment was administered to 76% of patients and complete remission (CR) was obtained in 39%. One hundred and ninety patients received at least one other treatment, including 10 already in CR after eradication. Altogether, CR was obtained in 70% of patients and the 5-year overall survival was 79% (95% CI [75-83]).

CONCLUSIONS

In comparison to clinical series, in the general population, GMLs are more frequently diagnosed at an advanced stage, their clinical management is heterogeneous, and there is a risk of misdiagnosis and overtreatment. These results highlight the necessity of following currently available guidelines in this field.

Для цитирования: Matysiak-Budnik Tamara, Jamet Philippe, Ruskoné-Fourmestraux Agnès, de Mascarel Antoine, Velten Michel, Maynadié Marc, Woronoff Anne-Sophie, Trétarre Brigitte, Marrer Emilie, Delafosse Patricia, Ligier Karine, Lapôtre Ledoux Bénédicte, Daubisse Laetitia, Bouzid Laïla, Orazio Sébastien, Cowppli-Bony Anne, Monnereau Alain. Gastric MALT lymphoma in a population-based study in France: clinical features, treatments and survival.. Alimentary pharmacology & therapeutics. 2019. DOI: 10.1111/apt.15409.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.